Compile Data Set for Download or QSAR
Report error Found 194 Enz. Inhib. hit(s) with all data for entry = 1458
TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324123(US10189816, Compound 116)
Affinity DataEC50:  2nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324052(US10189816, Compound 45)
Affinity DataEC50:  3nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324136(US10189816, Compound 129)
Affinity DataEC50:  3nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324087(US10189816, Compound 80)
Affinity DataEC50:  3nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324030(US10189816, Compound 23)
Affinity DataEC50:  3nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324058(US10189816, Compound 51)
Affinity DataEC50:  3nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324171(US10189816, Compound 164)
Affinity DataEC50:  3nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324103(US10189816, Compound 96)
Affinity DataEC50:  3nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324014(US10189816, Compound 7)
Affinity DataEC50:  4nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM323830(US10189816, Compound 1)
Affinity DataEC50:  6nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324045(US10189816, Compound 38)
Affinity DataEC50:  6nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324080(US10189816, Compound 73)
Affinity DataEC50:  7nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324163(US10189816, Compound 156)
Affinity DataEC50:  8nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324151(US10189816, Compound 144)
Affinity DataEC50:  8nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324117(US10189816, Compound 110)
Affinity DataEC50:  8nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324038(US10189816, Compound 31)
Affinity DataEC50:  11nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324130(US10189816, Compound 123)
Affinity DataEC50:  11nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324110(US10189816, Compound 103)
Affinity DataEC50:  12nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324095(US10189816, Compound 88)
Affinity DataEC50:  12nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324141(US10189816, Compound 134)
Affinity DataEC50:  12nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324073(US10189816, Compound 66)
Affinity DataEC50:  13nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324157(US10189816, Compound 150)
Affinity DataEC50:  21nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324173(US10189816, Compound 166)
Affinity DataEC50:  23nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324146(US10189816, Compound 139)
Affinity DataEC50:  30nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324021(US10189816, Compound 14)
Affinity DataEC50:  34nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324066(US10189816, Compound 59)
Affinity DataEC50:  58nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324170(US10189816, Compound 163)
Affinity DataEC50:  76nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324160(US10189816, Compound 153)
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324159(US10189816, Compound 152)
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324162(US10189816, Compound 155)
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324161(US10189816, Compound 154)
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324163(US10189816, Compound 156)
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324165(US10189816, Compound 158)
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324164(US10189816, Compound 157)
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324153(US10189816, Compound 146)
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324152(US10189816, Compound 145)
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324155(US10189816, Compound 148)
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324154(US10189816, Compound 147)
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324157(US10189816, Compound 150)
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324156(US10189816, Compound 149)
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324158(US10189816, Compound 151)
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324173(US10189816, Compound 166)
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324172(US10189816, Compound 165)
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324167(US10189816, Compound 160)
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324166(US10189816, Compound 159)
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324169(US10189816, Compound 162)
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324024(US10189816, Compound 17 | US10189816, Compound 161)
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324170(US10189816, Compound 163)
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM324171(US10189816, Compound 164)
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM323830(US10189816, Compound 1)
Affinity DataEC50: <100nMAssay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

Displayed 1 to 50 (of 194 total ) | Next | Last >>
Jump to: